|
|
Monitoring Blood Pressure at Home May Help Keep It Low Daily readings and pre-agreed med changes yielded better results than standard care in study
By
Steven Reinberg HealthDay Reporter
(HealthDay News) -- With proper training, people with high blood pressure may be able to control it more effectively on their
own at home than through conventional methods, British researchers contend.
Through telemonitoring of their blood
pressure and adjusting their medications according to guidelines agreed upon in advance, patients assigned to self-managed
care saw greater reductions in blood pressure after six and 12 months than patients receiving standard care through health
professionals, the study found.
"Self-management represents an important new intervention for people with hypertension
treated in primary care," said lead researcher Dr. Richard J. McManus, a professor of primary care cardiovascular research
and honorary consultant at the University of Birmingham in England.
Self-management should be considered for people
with hypertension, particularly if their blood pressure is not controlled with standard care, McManus added.
But the
self-managed approach is not without drawbacks, McManus noted.
"Caveats are that not everyone will want to do self-management
and that family doctors need to be involved in setting up the titration schedules for individuals to follow," he said.
High
blood pressure is a major risk factor for heart attack, heart failure, stroke and renal (kidney) failure, but only half the
people treated for it have their blood pressure controlled, according to background information in the study.
For
the study, published in the July 8 online edition of The Lancet, McManus's team randomly assigned 527 patients with
high blood pressure, also known as hypertension, to either self-managed care or to standard care.
Taking daily blood
pressure readings over six months, patients managing their own care saw a drop in systolic blood pressure (the top number
in a 120/80 reading) of 12.9 mm Hg, while patients on standard therapy saw only a 9.2 mm Hg drop in systolic pressure, the
researchers found.
After a year, systolic pressure in the self-managed group fell 17.6 mm Hg, compared with 12.2 mm
Hg in the standard care group.
Patients without diabetes were encouraged to aim for 130/85 mm Hg, and diabetics were
to target 130/75 mm Hg, according to the study.
Side effects were generally the same in both groups, except that leg
swelling occurred more often in the self-managed group (32 percent versus 22 percent), the researchers note.
The self-managed
patients attended two training sessions to learn to use automated sphygmomanometers (blood pressure monitors), and they were
also taught how to transmit their blood pressure readings to the doctor via an automated modem device.
Drug-adjustment
schedules were agreed to by the patients and their family doctor.
McManus thinks that working actively to control
blood pressure is the reason the self-management approach was so successful.
"The effect seems to be due to increased
antihypertensive treatment in people who self-manage," he said. For example, patients who missed their targets two months
in a row made medication changes.
Dr. Gregg C. Fonarow, professor of medicine and director of the Ahmanson-UCLA Cardiomyopathy
Center at the University of California, Los Angeles, said self-management has been shown to improve risk factor control or
outcomes in patients with other conditions, such as diabetes and heart failure.
"This exciting new study demonstrates
that the combination of telemonitoring of home blood pressure measurements combined with self-management of hypertension following
a simple algorithm was more effective than usual care in the primary care setting," Fonarow said.
"This represents
a very practical, broadly applicable, likely cost-effective new approach to achieve improved blood pressure control," he said.
More information
For more information on hypertension, visit the U.S. National Library of Medicine. SOURCES: Richard J McManus, M.R.C.G.P., professor of primary care cardiovascular research
and honorary consultant, University of Birmingham, England; Gregg C. Fonarow, M.D., professor, medicine, and director, Ahmanson-UCLA
Cardiomyopathy Center, University of California, Los Angeles; July 8, 2010, The Lancet, online
|
|
|
|
|